Skip to content
Abbott logo

Equity

Abbott·Balance Sheet Statement·8 metrics

Breakdown

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total liabilities and stockholders' equity$73B$74.4B$81.4B$81.4B$84B$84.2B$86.7B$110.4B
Total stockholders' equity$39.3B$39.8B$47.7B$48.8B$50.6B$51B$52.1B$52.1B
Retained earnings$38.4B$39.1B$47.3B$47.7B$48.5B$49.1B$49.8B$50B
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$24.9B$25B$25.2B$25.1B$25.3B$25.4B$25.5B$25.4B
Treasury stock$15.8B$16.5B$16.8B$16.6B$16.6B$16.9B$17.2B$16.9B
Accumulated other comprehensive income (loss)-$8.1B-$7.8B-$7.9B-$7.4B-$6.6B-$6.7B-$6B-$6.3B
AOCI - Cash Flow Hedge Adjustment$156M-$24M$210M$119M-$66M-$27M-$69M$33M
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0$0$0$0$0$0$0$0

Metrics

Accumulated other comprehensive income (loss)

View metric

AOCI - Cash Flow Hedge Adjustment

View metric

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

View metric

Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding

View metric

Retained earnings

View metric

Total liabilities and stockholders' equity

View metric

Total stockholders' equity

View metric

Treasury stock

View metric